Generalisability of survival estimates for patients with breast cancer -: A comparison across two population-based series

被引:22
作者
Lundin, Johan
Lehtimaki, Tiina
Lundin, Mikael
Holli, Kaija
Elomaa, Liisa
Turpeenniemi-Hujanen, Taina
Kataja, Vesa
Isola, Jorma
Joensuu, Heikki
机构
[1] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland
[2] Tampere Univ Hosp, Dept Oncol, Dept Palliat Med, Tampere, Finland
[3] Univ Turku, Cent Hosp, Dept Oncol, Turku, Finland
[4] Oulu Univ, Cent Hosp, Dept Radiotherapy & Oncol, SF-90220 Oulu, Finland
[5] Kuopio Univ Hosp, Dept Oncol, SF-70210 Kuopio, Finland
[6] Tampere Univ, Inst Med Oncol, FIN-33101 Tampere, Finland
[7] Tampere Univ Hosp, Tampere, Finland
[8] Folkhalsan Res Ctr, Helsinki, Finland
关键词
breast neoplasms; prognostic factors; survival oestrogen receptor; progesterone receptor; ADJUVANT THERAPY; UNITED-STATES; CHEMOTHERAPY; MAMMOGRAPHY; RECURRENCE; DECISIONS; TAMOXIFEN; PROGRAM; WOMEN; RISK;
D O I
10.1016/j.ejca.2006.06.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the study was to analyse the generalisability and geographic transportability of survival estimates produced by commonly used prognostic factors. We compared the influence of tumour size, histologic grade, axillary nodal status, oestrogen and progesterone receptor contents, age at diagnosis and two prognostication schemes (the Nottingham Prognostic Index and St. Gallen criteria) in two nationwide cohorts of patients diagnosed with breast cancer in 1991-2, the FinProg (n = 2923, Finland) and the SEER series (n = 43,249, the United States (US)). Eight-year estimates of breast cancer-specific (84% versus 80%), relative (86% versus 83%), and overall (70% versus 69%) survival were slightly more favourable in the SEER than in the FinProg series, respectively. Despite differences in demographic variables and the frequency of use of adjuvant therapies and mammography screening between the series, the prognostic factors examined produced close to overlapping survival curves with similar shapes. The results suggest that quantitative survival estimates based on frequently used prognostic factors and prognostication schemes are generalisable and transportable between large, unselected cohorts of breast cancer patients. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3228 / 3235
页数:8
相关论文
共 25 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations [J].
Armstrong, K ;
Weber, B ;
Ubel, PA ;
Peters, N ;
Holmes, J ;
Schwartz, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9319-9328
[3]   Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys [J].
Breen, N ;
Wagener, DK ;
Brown, ML ;
Davis, WW ;
Ballard-Barbash, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22) :1704-1713
[4]   Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? [J].
Brenton, JD ;
Carey, LA ;
Ahmed, AA ;
Caldas, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7350-7360
[5]  
Dean PB, 1999, ACTA ONCOL, V38, P47
[6]  
Ederer F., 1959, Instructions to IBM 650 programmers in processing survival computations
[7]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219
[8]   Meeting highlights:: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [J].
Goldhirsch, A ;
Glick, JH ;
Gelber, RD ;
Coates, AS ;
Thürlimann, B ;
Senn, H ;
Albain, KS ;
Bergh, J ;
Castiglione-Gertsch, M ;
Coates, AS ;
Costa, A ;
Cuzick, J ;
Davidson, N ;
Forbes, JF ;
Gelber, RD ;
Goss, P ;
Harris, J ;
Glick, JH ;
Goldhirsch, A ;
Howell, A ;
Ingle, JN ;
Jakesz, R ;
Jassem, J ;
Kaufmann, M ;
Martin, M ;
Mauriac, L ;
Morrow, M ;
Mouridsen, HT ;
Namer, M ;
Piccart-Gebhart, MJ ;
Possinger, K ;
Pritchard, K ;
Rutgers, EJT ;
Thürlimann, B ;
Viale, G ;
Wallgren, A ;
Wood, WC .
ANNALS OF ONCOLOGY, 2005, 16 (10) :1569-1583
[9]   Adjuvant therapy for breast cancer: Practice patterns of community physicians [J].
Harlan, LC ;
Abrams, J ;
Warren, JL ;
Clegg, L ;
Stevens, J ;
Ballard-Barbash, R .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1809-1817
[10]   Risk for distant recurrence of breast cancer detected by mammography screening or other methods [J].
Joensuu, H ;
Lehtimäki, T ;
Holli, K ;
Elomaa, L ;
Turpeenniemi-Hujanen, T ;
Kataja, V ;
Anttila, A ;
Lundin, M ;
Isola, J ;
Lundin, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (09) :1064-1073